Global and Tropical Health

Medicine and Dentistry

1. Patient 100%
2. Therapeutic Procedure 72%
3. Infection 66%
4. Child 63%
5. Diseases 46%
6. Malaria 46%
7. Diagnosis 38%
8. Hospital 36%
9. Analysis 32%
10. Scabies 27%
11. Health 26%
12. Cohort Effect 24%
13. Adult 21%
14. Burkholderia pseudomallei 21%
15. Rheumatic Heart Disease 19%
16. Randomized Controlled Trial 19%
17. Malaria Falciparum 19%
18. Woman 17%
19. Vaccine 17%
20. Systematic Review 16%
21. Infant 16%
22. Rheumatic Fever 16%
23. Tuberculosis 15%
24. Mortality 15%
25. Age 15%
26. Public Health 13%
27. Plasmodium Vivax Malaria 13%
28. Incidence 12%
29. Laboratory 12%
30. Development 12%
31. COVID-19 11%
32. Sepsis 11%
33. Pneumococcus Vaccine 11%
34. Pneumonia 11%
35. Pregnancy 11%
36. Culture 10%
37. Pathogen 10%
38. Pediatrics 10%
39. Anti-biotics 9%
40. Observational Study 9%
41. Screening 8%
42. Follow up 8%
43. Meta-Analysis 8%
44. Water 8%
45. Clinical Trial 8%
46. Prospective Study 8%
47. Association 8%
48. Bloodstream Infection 8%
49. Health Care Cost 8%
50. Cohort Analysis 8%
51. Assay 8%
52. Glucose 6 Phosphate Dehydrogenase 8%
53. Primary Health Care 7%
54. Clinician 7%
55. Skin Infection 7%
56. Experience 7%
57. Parasite (Microbiology) 7%
58. Staphylococcus Aureus 7%
59. Physician 7%
60. Impetigo 7%
61. Drug 7%
62. Symptom 6%
63. Case Report 6%
64. Cross Sectional Study 6%
65. Lung 6%
66. Morbidity 6%
67. Nitric Oxide 6%
68. Aboriginal and Torres Strait Islander 6%
69. Male 6%
70. Influenza 6%
71. Prophylaxis 5%
72. Hygiene 5%
73. Comprehension 5%
74. Organism 5%
75. Prospective Cohort Study 5%
76. Human 5%
77. Fever 5%
78. Health Service 5%
79. Antimalarial Agent 5%
80. Household 5%
81. Drug Administration 5%
82. Childhood 5%
83. Artemisinin 5%
84. Microscopy 5%